European Society for Medical Oncology Preceptorship on Ovarian Cancer 2023 Lisbon

European Society for Medical Oncology Preceptorship on Ovarian Cancer 2023 Lisbon

$20.00

+ Include: 25 videos + 26 pdfs, size: 2.58 GB

+ Target Audience: oncologist

Description

+ Include: 25 videos + 26 pdfs, size: 2.58 GB

+ Target Audience: oncologist

+ Sample video: contact me for sample video

+ Information:

Start date: 15 Sep 2023
End date: 16 Sep 2023
Location: Lisbon, Portugal

Learning objectives

  • To learn about best clinical practice in the multidisciplinary management of early and late stage ovarian cancer
  • To understand the importance of biology and pathology of common and rare ovarian tumours
  • To understand the options for treatment of recurrent disease and how treatment decisions are made
  • To understand the novel therapeutic agents being developed to treat ovarian cancer and how knowledge of genomics and molecular pathways guides drug development
  • To learn about the management of patients with symptoms of the disease and the side effects of treatment

 

+ Topics:

ESMO-Preceptorship-on-Ovarian-Cancer-2023-Lisbon-Programme.pdf

Session 1 Early Stage Clinical Management of Early Ovarian Cancer.mp4

Session 1 Early Stage Clinical Management of Early Ovarian Cancer.pdf

Session 2 Rare Cancers – Part I Germ Cells Tumours.mp4

Session 2 Rare Cancers – Part I Germ Cells Tumours.pdf

Session 2 Rare Cancers – Part I Sex-cord Stromal Tumours.mp4

Session 2 Rare Cancers – Part I Sex-cord Stromal Tumours.pdf

Session 3 Advanced Disease at Diagnosis Biology of High-grade Tubo-epithelial Cancers, Including Biomarkers in Practice.mp4

Session 3 Advanced Disease at Diagnosis Biology of High-grade Tubo-epithelial Cancers, Including Biomarkers in Practice.pdf

Session 3 Advanced Disease at Diagnosis First-line Chemotherapy (Including Maintenance) Treatment.mp4

Session 3 Advanced Disease at Diagnosis First-line Chemotherapy (Including Maintenance) Treatment.pdf

Session 3 Advanced Disease at Diagnosis Participants Clinical Case Discussion A Case of Adverse Events.mp4

Session 3 Advanced Disease at Diagnosis Participants Clinical Case Discussion A Case of Adverse Events.pdf

Session 3 Advanced Disease at Diagnosis Participants Clinical Case Discussion BRCA1 and Ovarian Cancer.mp4

Session 3 Advanced Disease at Diagnosis Participants Clinical Case Discussion BRCA1 and Ovarian Cancer.pdf

Session 3 Advanced Disease at Diagnosis Participants Clinical Case Discussion Stage IIIC High Grade Serous Ovarian Carcinoma.mp4

Session 3 Advanced Disease at Diagnosis Participants Clinical Case Discussion Stage IIIC High Grade Serous Ovarian Carcinoma.pdf

Session 3 Advanced Disease at Diagnosis Surgery for Newly Diagnosed Advanced Ovarian Cancer.mp4

Session 3 Advanced Disease at Diagnosis Surgery for Newly Diagnosed Advanced Ovarian Cancer.pdf

Session 4 Early Stage – Part II Overview on Pathology, Classification of Early Epithelial Carcinoma.mp4

Session 4 Early Stage – Part II Overview on Pathology, Classification of Early Epithelial Carcinoma.pdf

Session 4 Early Stage – Part II Surgery for Early Ovarian Cancer Staging.mp4

Session 4 Early Stage – Part II Surgery for Early Ovarian Cancer Staging.pdf

Session 5 Rare Cancers – Part II Rare Epithelial Tumours Low-grade Serous, Clear Cell and Mucinous.mp4

Session 5 Rare Cancers – Part II Rare Epithelial Tumours Low-grade Serous, Clear Cell and Mucinous.pdf

Session 6 Recurrent Disease and Complex Cases – Part I Overview of Systemic Treatment for Recurrent Ovarian Cancer Platinum-based and Platinum-free.mp4

Session 6 Recurrent Disease and Complex Cases – Part I Overview of Systemic Treatment for Recurrent Ovarian Cancer Platinum-based and Platinum-free.pdf

Session 6 Recurrent Disease and Complex Cases – Part I Participants Clinical Case Discussion Ovarian Cancer.mp4

Session 6 Recurrent Disease and Complex Cases – Part I Participants Clinical Case Discussion Ovarian Cancer.pdf

Session 6 Recurrent Disease and Complex Cases – Part I Participants Clinical Case Discussion Overcoming the Odds.mp4

Session 6 Recurrent Disease and Complex Cases – Part I Participants Clinical Case Discussion Overcoming the Odds.pdf

Session 6 Recurrent Disease and Complex Cases – Part I Participants Clinical Case Discussion Turn of Events in an Endometrioid Ovarian Carcinoma.mp4

Session 6 Recurrent Disease and Complex Cases – Part I Participants Clinical Case Discussion Turn of Events in an Endometrioid Ovarian Carcinoma.pdf

Session 6 Recurrent Disease and Complex Cases – Part I The Role of Radiotherapy in Ovarian Cancer.mp4

Session 6 Recurrent Disease and Complex Cases – Part I The Role of Radiotherapy in Ovarian Cancer.pdf

Session 6 Recurrent Disease and Complex Cases – Part I The Role of Surgery in Recurrent Ovarian Cancer.mp4

Session 6 Recurrent Disease and Complex Cases – Part I The Role of Surgery in Recurrent Ovarian Cancer.pdf

Session 7 Recurrent Disease and Complex Cases – Part II Fertility-sparing surgery A Clinical Case.mp4

Session 7 Recurrent Disease and Complex Cases – Part II Fertility-sparing surgery A Clinical Case.pdf

Session 7 Recurrent Disease and Complex Cases – Part II Management of Ovarian Cancer in Older and Frail Patients.mp4

Session 7 Recurrent Disease and Complex Cases – Part II Management of Ovarian Cancer in Older and Frail Patients.pdf

Session 7 Recurrent Disease and Complex Cases – Part II Role of HIPEC in Ovarian Cancer.mp4

Session 7 Recurrent Disease and Complex Cases – Part II Role of HIPEC in Ovarian Cancer.pdf

Session 8 Biology and Methodologies All We Need to Develop Future Strategies Clinical Trial Design, Meta-analysis, PRO and QoL.mp4

Session 8 Biology and Methodologies All We Need to Develop Future Strategies Clinical Trial Design, Meta-analysis, PRO and QoL.pdf

Session 8 Biology and Methodologies All We Need to Develop Future Strategies Drug Resistance and How to Overcome PARP Inhibitors Resistance.mp4

Session 8 Biology and Methodologies All We Need to Develop Future Strategies Drug Resistance and How to Overcome PARP Inhibitors Resistance.pdf

Session 9 Future Treatments Novel Treatment Pathways and Combinations Horizon Scanning.mp4

Session 9 Future Treatments Novel Treatment Pathways and Combinations Horizon Scanning.pdf

Welcome and Introduction.mp4

Welcome and Introduction.pdf

Reviews

There are no reviews yet.

Be the first to review “European Society for Medical Oncology Preceptorship on Ovarian Cancer 2023 Lisbon”

Your email address will not be published. Required fields are marked *

Related Products